• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
TRACON Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011 Product Image

TRACON Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011

  • ID: 1801385
  • May 2011
  • 32 pages
  • Global Markets Direct

TRACON Pharmaceuticals, Inc. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “TRACON Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- TRACON Pharmaceuticals, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of TRACON Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
TRACON Pharmaceuticals, Inc. Snapshot
TRACON Pharmaceuticals, Inc. Overview
Key Information
Key Facts
TRACON Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
TRACON Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Pipeline Products Glance
TRACON Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
TRACON Pharmaceuticals, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Drug Profiles
TRC093
Product Description
Mechanism of Action
R&D Progress
TRC102 + Alimta
Product Description
Mechanism of Action
R&D Progress
TRC102 + Temodar
Product Description
Mechanism of Action
R&D Progress
TRC105
Product Description
Mechanism of Action
R&D Progress
TRC093
Product Description
Mechanism of Action
R&D Progress
TRC105
Product Description
Mechanism of Action
R&D Progress
TRACON Pharmaceuticals, Inc. – Pipeline Analysis
TRACON Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
TRACON Pharmaceuticals, Inc. - Pipeline Products By Target
TRACON Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
TRACON Pharmaceuticals, Inc. – Pipeline Products by Molecule Type
TRACON Pharmaceuticals, Inc. – Recent Pipeline Updates
TRACON Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
TRACON Pharmaceuticals, Inc., Deals Summary, 2004 to 2011
TRACON Pharmaceuticals, Inc. Detailed Deal Summary
TRACON Enters Into Co-Development Agreement With NCI
Licensing Agreements
Micromet Enters Into License Agreement Agreement With TRACON Pharmaceuticals
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
TRACON Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
TRACON Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
TRACON Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
TRACON Pharmaceuticals, Inc. – Combination Treatment Modalities in Pipeline, 2011
TRACON Pharmaceuticals, Inc. - Phase I, 2011
TRACON Pharmaceuticals, Inc. - Pipeline By Therapeutic Class, 2011
TRACON Pharmaceuticals, Inc. - Pipeline By Target, 2011
TRACON Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2011
TRACON Pharmaceuticals, Inc. – Pipeline By Molecule Type, 2011
TRACON Pharmaceuticals, Inc. – Recent Pipeline Updates, 2011
TRACON Pharmaceuticals, Inc., Deals Summary, 2004 to 2011

List of Figures
TRACON Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
TRACON Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
TRACON Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
TRACON Pharmaceuticals, Inc. – Combination Treatment Modalities in Pipeline, 2011
TRACON Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2011
TRACON Pharmaceuticals, Inc. - Pipeline By Target, 2011
TRACON Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2011
TRACON Pharmaceuticals, Inc. – Pipeline By Molecule Type, 2011

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos